Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jian Zhou, Yue Yang, Duo Zhang, Liang Zhou, Fei Liu, Lei Tao & Li-Ming Lu. (2016) Association of the recurrence of vocal leukoplakia with MDM2-309 variants over a 2-year period: a prospective study. Acta Oto-Laryngologica 136:1, pages 95-99.
Read now
Read now
Linguo Xie, Yan Sun, Tao Chen, Dawei Tian, Yujuan Li, Yu Zhang, Na Ding, Zhonghua Shen, Hao Xu, Xuewu Nian, Nan Sha, Ruifa Han, Hailong Hu & Changli Wu. (2015) Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis. OncoTargets and Therapy 8, pages 3679-3690.
Read now
Read now
Georgina P. Sava, Helen E. Speedy & Richard S. Houlston. (2014) Candidate gene association studies and risk of chronic lymphocytic leukemia: a systematic review and meta-analysis. Leukemia & Lymphoma 55:1, pages 160-167.
Read now
Read now
Articles from other publishers (10)
Scott Bang, Heeruk C. Bhatt, Yun Yue Chen & Manabu Kurokawa. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
3021
3028
.
Scott Bang, Heeruk C. Bhatt, Yun Yue Chen & Manabu Kurokawa. 2016. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1
8
.
B. Chen, M.-M. Xiong & X.-L. Meng. (2015) Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility. Diseases of the Esophagus 28:6, pages 593-601.
Crossref
Crossref
Mohammad Hashemi, Majid Naderi, Ebrahim Eskandari Nasab, Seyed Shahaboddin Hasani, Simin Sadeghi Bojd & Mohsen Taheri. (2015) Evaluation of 40-bp Insertion/Deletion Polymorphism of MDM2 and the Risk of Childhood Acute Lymphoblastic Leukemia. Gene, Cell and Tissue 2:1.
Crossref
Crossref
Xuepeng He, Peng Chen, Kai Yang, Bing Liu, Yuan Zhang, Fang Wang, Zhi Guo, Xiaodong Liu, Jinxing Lou & Huiren Chen. (2015) Association of MDM2 Polymorphism with Risk and Prognosis of Leukemia: A Meta-Analysis. Acta Haematologica 133:4, pages 365-371.
Crossref
Crossref
Yi‐Chang Liu, Hui‐Hua Hsiao, Wen‐Chi Yang, Ta‐Chih Liu, Chao‐Sung Chang, Ming‐Yu Yang, Pai‐Mei Lin, Jui‐Feng Hsu, Ching‐Ping Lee & Sheng‐Fung Lin. (2013) MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: The association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast‐free survival in chronic phase patients receiving imatinib. Molecular Carcinogenesis 53:12, pages 951-959.
Crossref
Crossref
Xianlu Zhuo, Jie Ren, Dairong Li, Yongzhong Wu & Qi Zhou. (2014) MDM2 SNP309 variation increases cervical cancer risk among Asians. Tumor Biology 35:6, pages 5331-5337.
Crossref
Crossref
Qi-Wen Chen, Hao Chen, Jian-Shan Cheng & Zhi-Qiang Meng. (2013) MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis. Tumor Biology 35:5, pages 4147-4151.
Crossref
Crossref
Simon Blechman Zeichner, Sarah Alghamdi, Gina Elhammady, Robert John Poppiti & Amilcar Castellano-Sanchez. (2014) Prognostic Significance of TP53 Mutations and Single Nucleotide Polymorphisms in Acute Myeloid Leukemia: A case Series and Literature Review. Asian Pacific Journal of Cancer Prevention 15:4, pages 1603-1609.
Crossref
Crossref
Jianfei Tang, Longxiang Shen, Sa Song, Zhiquan An & Changqing Zhang. (2013) Polymorphisms in the MDM2 gene and risk of malignant bone tumors: a meta-analysis. Tumor Biology 35:1, pages 779-784.
Crossref
Crossref